The premise of personalized immunotherapy for cancer dormancy

Progress in cancer therapies has resulted in improved survival of patients with early stage breast cancer. However, mortality remains high in patients with distant recurrence of the disease after initially successful treatment of early stage breast cancer. To this end, tumor recurrences have been at...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Oncogene 2020-05, Vol.39 (22), p.4323-4330
1. Verfasser:	Manjili, Masoud H.
Format:	Artikel
Sprache:	eng
Schlagworte:	631/250/251 631/250/580/1884 Adjuvant treatment Antigens Antigens, Neoplasm - immunology Apoptosis Breast cancer Cancer Cancer immunotherapy Cancer therapies Cancer Vaccines - therapeutic use Cell Biology Cell Division Disease-Free Survival Diseases Dormancy Drug therapy Forecasting Health aspects Human Genetics Humans Immunotherapy Internal Medicine Medicine Medicine & Public Health Models, Immunological Neoantigens Neoplasm Metastasis - immunology Neoplasm Metastasis - pathology Neoplasm Metastasis - prevention & control Neoplasms - immunology Neoplasms - pathology Neoplasms - therapy Neoplastic Stem Cells - immunology Oncology Patients Practice guidelines (Medicine) Precision Medicine Prevention Radiation Radiation therapy Radiotherapy Relapse Review Article Tumor cells Tumor Escape Tumors Vaccines
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!